Your browser's JavaScript is disabled.

To properly view the content on this page, please enable JavaScript.

Publications

Uncategorized

All Publications

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron to Participate in Stifel 2022 Healthcare Conference

Geron Announces Presentations at Upcoming ASH Annual Meeting Including Long-term Phase 2 Data Showing Continuous Durable Transfusion Independence in Patients with Lower Risk MDS

Geron Corporation Reports Third Quarter 2022 Financial Results and Upcoming Expected Milestones

Geron to Announce Third Quarter 2022 Financial Results on November 3, 2022

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Appoints Biopharma Veteran John F. McDonald to Board of Directors

Geron to Present at Upcoming Investor Conferences

Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis

[facetwp facet="publication_load_more"]